We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.29B
AUM Growth
+$73M
Cap. Flow
+$288M
Cap. Flow %
8.77%
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$42.5M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.3M
3
SEER icon
Seer Inc
SEER
+$20.8M
4
GKOS icon
Glaukos
GKOS
+$17.9M
5
COO icon
Cooper Companies
COO
+$17.1M

Top Sells

Rank Stock Value
1
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$60.7M
2
NTLA icon
Intellia Therapeutics
NTLA
+$26.2M
3
ORGO icon
Organogenesis Holdings
ORGO
+$19.9M
4
LLY icon
Eli Lilly
LLY
+$15.1M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Consumer Staples 0.8%
3 Technology 0.71%
4 Industrials 0.71%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMPS
151
CALL
Compass Pathways
CMPS
$1.95B
$4.44M 0.14%
148,700
+119,400
+408% +$4.01M
AUPH icon
152
CALL
Aurinia Pharmaceuticals
AUPH
$2.06B
$4.43M 0.13%
+200,000
New +$3.17M
TBIO
153
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$4.38M 0.13%
21,843
-379
-2% -$96.2K
TPB icon
154
Turning Point Brands
TPB
$1.75B
$4.37M 0.13%
91,449
-9,610
-10% -$461K
DH icon
155
Definitive Healthcare
DH
$69.5M
$4.28M 0.13%
+100,000
New +$4.44M
CVAC
156
PUT
DELISTED
CureVac
CVAC
$4.19M 0.13%
76,700
-50,000
-39% -$3.01M
CLDX icon
157
Celldex Therapeutics
CLDX
$3.51B
$4.17M 0.13%
77,285
-27,771
-26% -$1.3M
ORGO icon
158
PUT
Organogenesis Holdings
ORGO
$232M
$4.05M 0.12%
+284,500
New +$4.42M
NKTR icon
159
Nektar Therapeutics
NKTR
$2.57B
$3.94M 0.12%
+14,636
New +$3.52M
MRVI icon
160
Maravai LifeSciences
MRVI
$863M
$3.8M 0.12%
+77,500
New +$3.78M
MRVI icon
161
PUT
Maravai LifeSciences
MRVI
$863M
$3.8M 0.12%
+77,500
New +$3.78M
QNCX icon
162
PUT
Quince Therapeutics
QNCX
$31.4M
$3.78M 0.11%
+206
New +$3.28M
IMGN
163
PUT
DELISTED
Immunogen Inc
IMGN
$3.69M 0.11%
+650,700
New +$3.76M
RGEN icon
164
PUT
Repligen
RGEN
$9.4B
$3.61M 0.11%
+12,500
New +$3.21M
VRAY
165
CALL
DELISTED
ViewRay, Inc.
VRAY
$3.6M 0.11%
500,000
-200,000
-29% -$1.26M
CRVS icon
166
Corvus Pharmaceuticals
CRVS
$1.27B
$3.55M 0.11%
+734,268
New +$2.17M
DCPH
167
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$3.39M 0.1%
99,700
– –
SNAX
168
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$3.08M 0.09%
+38,333
New +$4.37M
MNKD icon
169
PUT
MannKind Corp
MNKD
$1.24B
$3.04M 0.09%
+700,000
New +$3.15M
AZN icon
170
AstraZeneca
AZN
$245B
$3M 0.09%
+25,000
New +$2.91M
FATE icon
171
PUT
Fate Therapeutics
FATE
$316M
$2.96M 0.09%
+50,000
New +$3.92M
IRTC icon
172
CALL
iRhythm Holdings
IRTC
$4.14B
$2.93M 0.09%
50,000
-185,600
-79% -$9.84M
QTNT
173
CALL
DELISTED
Quotient Limited Ordinary Shares
QTNT
$2.88M 0.09%
+30,798
New +$3.85M
BHC icon
174
Bausch Health
BHC
$2.32B
$2.79M 0.08%
+100,000
New +$2.84M
BNGO icon
175
Bionano Genomics
BNGO
$13.7M
$2.75M 0.08%
833
-834
-50% -$2.92M
5 6
7
8 9

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.

  • Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
  • Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
  • Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
  • Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
  • Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
  • Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
  • Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.